QIAGEN Partners to Develop Novel Companion Diagnostic in Lung Cancer
Go back to QIAGEN Partners to Develop Novel Companion Diagnostic in Lung Cancer| MIRATI THER (NASDAQ: MRTX) | Delayed: 58.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.70 | 52 Week High | $41.19 | |||
| Open | $48.72 | 52 Week Low | $4.40 | |||
| Day High | $58.70 | P/E | N/A | |||
| Day Low | $58.70 | EPS | $-5.39 | |||
| Volume | 400 | |||||
| Qiagen NV (NYSE: QGEN) | Delayed: 44.50 +2.18 (5.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.32 | 52 Week High | $28.50 | |||
| Open | $43.44 | 52 Week Low | $19.94 | |||
| Day High | $44.82 | P/E | 153.45 | |||
| Day Low | $43.39 | EPS | $0.29 | |||
| Volume | 4,809,759 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
